Transderm, Inc.
Records under this name other than the patents Transderm, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 5 of 5 · Back to Transderm, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,855,252 | Methods of treating keratin hyperproliferation disorders using mTOR inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,205,080 | Methods of treating keratin hyperproliferation disorders using mTOR inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,172,789 | Compositions for transdermal delivery of mTOR inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,723,314 | Methods and compositions for treating pachyonychia congenita Formerly held In force Term ended Nov 8, 2026 · From the USPTO record | In force | Term ended Nov 8, 2026 | From the USPTO record |
| US 10,695,548 | GENE SILENCING IN SKIN USING SELF-DELIVERY siRNA DELIVERED BY A MESO DEVICE Lapsed on the fee record Ended Jun 30, 2024 · Medium confidence | Lapsed on the fee record | Ended Jun 30, 2024 | Medium confidence |